解读瘤微环境中的代谢对话:从免疫抑制到精确的癌症疗法
Ruoli Wang1, Jincheng Zhuang1, Qi Zhang1
1Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Experimental hematology & oncology
|July 22, 2025
概括
瘤微环境 (TME) 是一种代谢战场. 重新编程免疫细胞代谢提供了一种有希望的策略,以克服癌症治疗抵抗力并提高免疫疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
- 在瘤学瘤学.
背景情况:
- 瘤微环境 (TME) 的特点是癌症和免疫细胞之间的代谢竞争.
- 免疫细胞 (巨细胞,T细胞,DCs) 的代谢重编程会影响它们的功能和抗瘤活性.
- 在TME中,缺氧,酸性和营养缺乏会促进免疫抑制性免疫表型和治疗耐药性.
研究的目的:
- 审查当前对调节TME内的免疫细胞行为的代谢检查点的理解.
- 要突出涉及免疫逃避的代谢酶和代谢物.
- 讨论针对癌症治疗的免疫代谢的新型治疗策略.
主要方法:
- 文献综述综合了免疫代谢的最新进展.
- 专注于关键的代谢途径:糖解,氧化酸化 (OXPHOS),脂质氧化,氨基酸代谢.
- 探索创新技术,如单细胞代谢学,空间分析和药物发现中的AI.
主要成果:
- 代谢酶 (IDO1,ACLY,CPT1A) 和代谢物 (乳酸盐,金氨酸) 是免疫逃避的关键调解者.
- 代谢重编程策略,包括双重向抑制剂和生物材料输送系统,在临床前模型中显示出前景.
- 了解代谢异质性是个性化癌症治疗的关键.
结论:
- 向免疫代谢是一种强大的方法,可以克服癌症的治疗耐药性.
- 翻译方面的挑战包括生物标志物验证,代谢可塑性和患者间的可变性.
- 重新编程免疫细胞代谢有可能重新定义精确瘤学并改善患者的治疗结果.
相关概念视频
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


